Markus Müschen is interested in basic aspects of Cancer Biology and Immunology including signal transduction from oncogenes and mechanisms of self-renewal and cellular quiescence. He developed his primary research interest both in the field of immunology (B cell development) and oncology (oncogenes in leukemia). He started his independent laboratory in 2001 in Cologne, Germany and moved with his group to Los Angeles in 2006 to serve as the Director of the Leukemia Research Program at Children’s Hospital Los Angeles and as the Program Leader of the Hematological Malignancies Program of the USC Norris Cancer Center. He was recently awarded a Cancer Research UK Chair of Molecular Pathology and the 2012 Sir Alexander Haddow Professorship of The Institute of Cancer Research (ICR), London, UK. He is currently a Scholar of the Leukemia and Lymphoma Society and a Senior Investigator of the Wellcome Trust, UK . In 2010, Markus Müschen joined the University of California San Francisco (UCSF) as full professor and serves as the Co-Leader of the Hematological Malignancies Program at the UCSF Helen-Diller-Family Comprehensive Cancer Center. His research involves multi-disciplinary approaches (Immunology, hematology/oncology, signal transduction, computational biology) and has a genuine translational focus towards development of pathway-specific drug-design.
